Funding

Semble Raises £30M In Series C Round Led by Revaia

Jun 4, 2026 | By Team SR

Semble, a UK-based healthcare technology company, has raised £30 million in a Series C round led by Revaia, with participation from Partech, Mercia Ventures, and Octopus Ventures.

SUMMARY

  • Semble, a UK-based healthcare technology company, has raised £30 million in a Series C round led by Revaia, with participation from Partech, Mercia Ventures, and Octopus Ventures.

The company provides a unified practice management and care coordination platform for outpatient healthcare providers.

Its software helps clinicians and healthcare organisations manage patient journeys, streamline clinical and administrative workflows, and coordinate care through a single system.

More than 10 million patients have been treated via clinicians using Semble, and over 1,700 healthcare organisations including Nuffield Health, Welbeck, and London Doctors Clinic use its platform.

Read Also - Standard Chartered Appoints Shebani Baweja As Group Chief Data Officer

The new funding will support expansion across the UK and France, strengthen adoption among large healthcare groups, and further develop Semble’s AI-powered care orchestration capabilities.

What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe. Said Christoph Lippuner ,CEO and co-founder of Semble.

Recommended Stories for You